Cannabis Law Report

MARCH 7, 2023

MSW), Chief Knowledge Officer, New Frontier Data One of the defining characteristics of state medical cannabis programs is the list of qualifying conditions. Some states like Ohio, Pennsylvania and Michigan have finite lists of qualifying conditions with additions allowed […]

State Laws 52

State Laws Data Law Conditions 52

Veriheal

DECEMBER 14, 2021

An Analysis of Nationwide EVALI Data. Acknowledging this data, the study’s authors called for states to consider initiating home cultivation policies. As legalization efforts ramp up, experts hope to see an exponential decline in the occurrence of the condition.

Data 98

Data Vaping Legalization Consumption 98

Cannabis Law Report

JULY 29, 2021

According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. This Data Says So appeared first on Green Market Report.

Data 116

Data Legalization Education Programs 116

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

SpeedWeed

MAY 1, 2021

A bipartisan group of lawmakers from both houses of Congress reintroduced on Thursday the Marijuana Data Collection Act, a bill that would require the federal government to study the effects of legal cannabis. We need independent data on how these programs impact state budgets, the public health, and employment,” said Garcia.

Collective 52

Collective Data Marijuana Policy 52

Medicinal Genomics

JULY 9, 2020

We added new data visualizations and a variant table that displays Amino Acid changing SNPS in the THCA, CBDA, and CBCA synthase genes. After all, studies have shown that when THCA, CBCA, and CBDA are cloned into yeast, fed precursor, and subjected to certain conditions, they can create different cannabinoids.

Data 59

Data Cannabinoids Conditions Hemp 59

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings.

CBD 297

CBD Clinical Trials Data Treatment 297

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

MAY 1, 2022

A new report by New Frontier Data estimated that U.S. legal and illicit cannabis consumer spending reached an estimated US$97 billion in 2021, according to a new report by New Frontier Data. Cannabis is no longer a one-size-fits-all industry,” Gary Allen, CEO of New Frontier Data, said in a statement.

Data 52

Data Legalization Consumption Collective 52

Cannabis Law Report

AUGUST 20, 2022

CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021. Secretary of the Illinois Department of Financial and Professional Regulation.

Conditions 52

Conditions Dispensary Programs Business 52

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Healer

NOVEMBER 15, 2023

Let’s start by taking a look at the new data and what it means. First, it’s important to point out that I usually wait until new data makes its way through the scientific peer-review process and is published in a journal before giving it much time and energy. Were they using cannabis to treat another medical condition?

Data 126

Data Topical Research and Development Conditions 126

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. This data aligns with Americans’ rising acceptance of cannabis. The most popular qualifying conditions continue to be chronic pain and PTSD, some of which may be related to the pandemic.

Patients 108

Patients Chronic Pain Marijuana Conditions 108

The Cannigma

NOVEMBER 23, 2021

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry. Okay, we got to prove it. 0:14:10.3]

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s not clear whether the Department of Health will provide the data.

Data 52

Data Treatment Patients Chronic Pain 52

SpeedWeed

AUGUST 18, 2021

Gallup does not yet have sufficient data to provide reliable estimates for Generation Z, the oldest of whom are 24 years old now. The post Pennsylvania’s Medical Cannabis Board Rejects Requests to Expand State’s List of Qualifying Conditions appeared first on SpeedWeed. View original article.

Conditions 52

Conditions Education Data Edibles 52

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 344

Chronic Pain Clinical Trials Data Patients 344

Leaf Science

DECEMBER 28, 2018

The groundbreaking study conducted by New Frontier Data surveyed over 3,000 adult Americans to show people from all age groups and demographics in the U.S. The post New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S. are moving away from alcohol and pharmaceuticals in favour of cannabis use.

Pharmaceutical 84

Pharmaceutical Data Recreational Topical 84

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Veriheal

APRIL 23, 2024

By engaging individuals across various age groups and demographics, we gather insights into usage patterns, medical conditions, past substance experiences, and more. We have also used some information provided by New Frontier Data in 2022, which referenced various studies and findings on this age demographic’s substance use.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Cannabis Law Report

NOVEMBER 14, 2019

million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. More than half (56 per cent) of those using cannabis for their conditions did so on a daily basis, with a further 23 per cent on a weekly basis. They write.

Conditions 45

Conditions Data Medicine Collective 45

Cannabis Info

JULY 12, 2019

CBD for Pets Yes the Data says it works ! Plus, many of the conditions we’ll list below (like anxiety, arthritis , pain, and convulsions) manifest much in the same way in pets as they do in humans. Lets review some data. You diligently bring your dog to the Vet, pay the egregious bill , and do whatever the Vet says…….

Pets 45

Pets Data CBD Cannabinoids 45

WeedAdvisor

JULY 21, 2019

Marijuana may be a lucrative opportunity on the surface, but there are several conditions that could put the industry out of reach for some time. This is why we offer a variety of business solutions for functions like POS, compliance, inventory tracking, safety and real-time data monitoring. Strict Regulations. .

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 251

Clinical Trials Chronic Pain Cannabinoids Patients 251

Cannabis Law Report

NOVEMBER 19, 2019

(CSE:GRIN | OTC: GRUSF) (“ Grown Rogue ” or the “ Company ”), a vertically-integrated, multi-state cannabis company, with operations and assets in Oregon, California, and Michigan, has released survey data suggesting the pricing in the Oregon cannabis market is recovering. . Survey Highlights.

Data 45

Data Dispensary Retail Recreational 45

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 192

Clinical Trials Chronic Pain Data Treatment 192

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Life Network

FEBRUARY 24, 2023

The study, which analyzed data from 175,000 people, said cannabis consumers are 34% more likely to develop the heart condition. A recent American College of Cardiology study says daily cannabis use increases the risk of heart disease. Particularly coronary artery disease (CAD), which is the most common form of heart disease.

Research and Development 97

Research and Development Vaping Data Edibles 97

Cannabis Life Network

JUNE 23, 2023

Whitney Economics is a consulting and research firm that compiles cannabis economic data into annual reports. They published their findings in their second annual Cannabis Operator Sentiment and Business Conditions. While the Biden administration kicks the rescheduling of cannabis down the road for the 2024 election, only 24% of U.S.

Data 85

Data Conditions Business Cannabis 85

NORML

JUNE 19, 2020

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

Patients 349

Patients Chronic Pain Treatment Therapy 349

Project CBD

JUNE 20, 2023

One gastrointestinal condition long associated with self-medication through cannabis is inflammatory bowel disease (IBD). IBD in Puerto Rico In 2016, the government of Puerto Rico legalized medicinal cannabis for a relatively short list of specific conditions, including Crohn’s disease. A flurry of recent research bears this out.

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208